We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+1.59%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$8.2B
AUM Growth
-$1.43B
Cap. Flow
-$1.45B
Cap. Flow %
-17.65%
Top 10 Hldgs %
62.08%
Holding
95
New
4
Increased
10
Reduced
60
Closed
4

Top Sells

Rank Stock Value
1
SCI icon
Service Corp International
SCI
+$60.1M
2
V icon
Visa
V
+$57.8M
3
SNPS icon
Synopsys
SNPS
+$55.6M
4
AMZN icon
Amazon
AMZN
+$52.8M
5
MSFT icon
Microsoft
MSFT
+$52.7M

Sector Composition

Rank Sector Weight
1 Financials 21.38%
2 Technology 18.43%
3 Healthcare 14.52%
4 Consumer Discretionary 10.53%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SE icon
26
Sea Limited
SE
$65.8B
$33.5M 0.41%
315,849
-4,623
-1% -$486K
NTRA icon
27
Natera
NTRA
$36.3B
$31.7M 0.39%
200,000
-130,000
-39% -$18.9M
MMYT icon
28
MakeMyTrip
MMYT
$5.25B
$31.3M 0.38%
278,573
-3,993
-1% -$428K
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$124B
$27.2M 0.33%
67,557
DXCM icon
30
DexCom
DXCM
$29.1B
$27.1M 0.33%
349,000
GKOS icon
31
Glaukos
GKOS
$9.19B
$24.3M 0.3%
162,212
INSM icon
32
Insmed
INSM
$22.7B
$23.7M 0.29%
343,110
MDT icon
33
Medtronic
MDT
$112B
$23.2M 0.28%
290,000
SRPT icon
34
Sarepta Therapeutics
SRPT
$1.62B
$23.1M 0.28%
190,329
+50,000
+36% +$6.13M
PEN icon
35
Penumbra
PEN
$12.6B
$23M 0.28%
97,000
SCI icon
36
Service Corp International
SCI
$11.7B
$20M 0.24%
250,317
-735,244
-75% -$60.1M
BMRN icon
37
BioMarin Pharmaceuticals
BMRN
$12B
$20M 0.24%
303,851
INFY icon
38
Infosys
INFY
$50.6B
$18.7M 0.23%
852,969
-17,547
-2% -$393K
NVCR icon
39
NovoCure
NVCR
$1.81B
$18.5M 0.23%
621,784
+100,000
+19% +$2.12M
BEKE icon
40
KE Holdings
BEKE
$17.7B
$17.9M 0.22%
969,694
+934,302
+2,640% +$19.3M
ALGN icon
41
Align Technology
ALGN
$12.9B
$17.4M 0.21%
83,428
TME icon
42
Tencent Music
TME
$16.1B
$17M 0.21%
1,499,891
-22,360
-1% -$265K
KRYS icon
43
Krystal Biotech
KRYS
$10.6B
$16.6M 0.2%
105,809
-30,000
-22% -$5.32M
SNPS icon
44
Synopsys
SNPS
$73.1B
$16.5M 0.2%
33,898
-106,343
-76% -$55.6M
PTC icon
45
PTC
PTC
$14.9B
$15.9M 0.19%
86,439
-271,592
-76% -$51.5M
NBIX icon
46
Neurocrine Biosciences
NBIX
$18.2B
$15.7M 0.19%
115,000
+20,000
+21% +$2.47M
MELI icon
47
Mercado Libre
MELI
$94B
$15.4M 0.19%
9,061
-26,516
-75% -$51.6M
MSCI icon
48
MSCI
MSCI
$42.5B
$14.9M 0.18%
24,908
-77,409
-76% -$46.4M
VRSK icon
49
Verisk Analytics
VRSK
$28.7B
$14M 0.17%
50,820
-158,285
-76% -$44M
IONS icon
50
Ionis Pharmaceuticals
IONS
$9.09B
$14M 0.17%
400,000
+100,000
+33% +$3.74M

Similar funds

C WorldWide Group's Q4 2024 Portfolio in Review

As of Q4 2024, C WorldWide Group held 95 positions worth $8.2B, down 15% from $9.63B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

C WorldWide Group withdrew a net $1.45B in Q4 2024, closing 4 positions and reducing 60 holdings. Its most notable exit was Centene, an estimated $23.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, C WorldWide Group opened a new position in Alkermes worth $7.19M.

  • C WorldWide Group's largest Q4 2024 buy was Alkermes: 250,000 shares worth $7.19M.
  • C WorldWide Group added most to KE Holdings in Q4 2024, an estimated $19.3M increase.
  • C WorldWide Group's biggest Q4 2024 reduction was Service Corp International, cutting an estimated $60.1M.
  • C WorldWide Group fully exited Centene in Q4 2024, selling an estimated $23.5M.
  • C WorldWide Group's ten largest holdings make up 62% of its $8.2B portfolio in Q4 2024.
  • C WorldWide Group opened 4 new positions and closed 4 in Q4 2024.
  • C WorldWide Group's portfolio value fell 15% quarter-over-quarter to $8.2B.

Based on C WorldWide Group's 13F filing for Q4 2024, filed 4 Feb 2025.